Stocks and Investing
Stocks and Investing
Fri, July 31, 2020
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, July 30, 2020
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
John Ransom Maintained (AMED) at Buy with Increased Target to $255 on, Jul 30th, 2020
John Ransom of Raymond James, Maintained "Amedisys, Inc." (AMED) at Buy with Increased Target from $210 to $255 on, Jul 30th, 2020.
John has made no other calls on AMED in the last 4 months.
There is 1 other peer that has a rating on AMED. Out of the 1 peers that are also analyzing AMED, all agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Andrew Mok of "UBS" Maintained at Hold with Decreased Target to $190 on, Monday, May 11th, 2020
Contributing Sources